CLINICAL_TRIALS
trial_result
· 2019-07-26
Clinical Trial Update: Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects [Phase 1]
Summary
A Phase 1 methodology study evaluating 6-week food intake with liraglutide in obese subjects completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2019-07-26